TrialCardiovascular diabetology2021

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.

Andrei C Sposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.